Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Ranolazine	10
Overall Study	STARTED	Verapamil	10
Overall Study	STARTED	Lopinavir / Ritonavir	10
Overall Study	STARTED	Chloroquine	10
Overall Study	STARTED	Placebo	10
Overall Study	STARTED	Dofetilide and Diltiazem	10
Overall Study	COMPLETED	Ranolazine	10
Overall Study	COMPLETED	Verapamil	9
Overall Study	COMPLETED	Lopinavir / Ritonavir	10
Overall Study	COMPLETED	Chloroquine	10
Overall Study	COMPLETED	Placebo	10
Overall Study	COMPLETED	Dofetilide and Diltiazem	8
Overall Study	NOT COMPLETED	Ranolazine	0
Overall Study	NOT COMPLETED	Verapamil	1
Overall Study	NOT COMPLETED	Lopinavir / Ritonavir	0
Overall Study	NOT COMPLETED	Chloroquine	0
Overall Study	NOT COMPLETED	Placebo	0
Overall Study	NOT COMPLETED	Dofetilide and Diltiazem	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03070470/flow